Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack

Antiplatelet Therapy for AIS Patients With Thrombocytopenia

NCT06053021 ·Status: RECRUITING ·Phase: NA

Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE

NCT06853535 ·Status: RECRUITING ·Phase: PHASE3

Dose-Dependent Effect of Early Antiplatelet Therapy in Acute Ischemic Stroke

NCT01273935 ·Status: COMPLETED

Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke

NCT04491695 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Edoxaban for TIA and Acute Minor Stroke

NCT02221102 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Preventing Recurrent Vascular Events in Patients With Stroke or Transient Ischemic Attack

NCT00931788 ·Status: COMPLETED ·Phase: PHASE4

To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection

NCT00238667 ·Status: COMPLETED ·Phase: PHASE3

Effect of Aspirin at the Acute Phase of Cerebral Ischemic Event.

NCT01375400 ·Status: UNKNOWN ·Phase: NA

Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis

NCT03062319 ·Status: TERMINATED ·Phase: PHASE4

Early Antiplatelet for Minor Stroke Following Thrombolysis (EAST)

NCT05193071 ·Status: COMPLETED ·Phase: PHASE4

A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion

NCT02398656 ·Status: COMPLETED ·Phase: PHASE3

Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention

NCT01455935 ·Status: UNKNOWN ·Phase: PHASE2

Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)

NCT05439356 ·Status: COMPLETED ·Phase: PHASE3

Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives

NCT01563731 ·Status: COMPLETED ·Phase: PHASE4

AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke

NCT03192215 ·Status: TERMINATED ·Phase: PHASE3

Study for the Use of Alteplase in Patients Who Awaken With Stroke

NCT01150266 ·Status: WITHDRAWN ·Phase: PHASE1

Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds

NCT04504864 ·Status: UNKNOWN ·Phase: PHASE4

Intensive Drug Therapy for Ischemic Stroke

NCT05620615 ·Status: UNKNOWN

Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds

NCT05032053 ·Status: RECRUITING

Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic

NCT05415150 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin on Subarachnoid Hemorrhage-Induced Vasospasm

NCT00235963 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of Aspirin and TPA in Acute Ischemic Stroke

NCT00417898 ·Status: WITHDRAWN ·Phase: PHASE1

Clinical Trial to Evaluate the Safety of Continuous IV Tirofiban in Acute Ischemic Stroke

NCT04818944 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis

NCT06058130 ·Status: RECRUITING ·Phase: NA

Restart TICrH Alpha Pilot Protocol, Restarting DOACs After Traumatic Intracranial Hemorrhage

NCT04891861 ·Status: UNKNOWN ·Phase: PHASE3